Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study
Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study
Recruiting · NCT07669935 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, fetal growth restriction, hereditary endocrine growth disease, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder | Recruiting | Not stated | 2026-09-30 | NCT07669935 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medicines360 | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| St. Lawrence Health | Potsdam | United States | 3 |
| Woman's Hospital | Baton Rouge | United States | 28 |